{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:13:11Z","timestamp":1789056791513,"version":"build-2803163510"},"reference-count":0,"publisher":"Ideggyogyaszati Szemle Journal","issue":"11-12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ideggyogy Sz"],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:p>In aging societies, the morbidity and mortality of dementia is increasing at a significant rate, thereby imposing burden on healthcare, economy and the society as well. Patients\u2019 and caregivers\u2019 quality of life and life expectancy are greatly determined by the early diagnosis and the initiation of available symptomatic treatments. Cholinesterase inhibitors and memantine have been the cornerstones of Alzheimer\u2019s therapy for approximately two decades and over the years, more and more experience has been gained on their use in non-Alzheimer\u2019s dementias too. The aim of our work was to provide a comprehensive summary about the use of cholinesterase inhibitors and memantine for the treatment of Alzheimer\u2019s and non-Alzheimers\u2019s dementias.<\/jats:p>","DOI":"10.18071\/isz.74.0379","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T06:12:43Z","timestamp":1638339163000},"page":"379-387","source":"Crossref","is-referenced-by-count":56,"title":["Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias"],"prefix":"10.18071","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-2563","authenticated-orcid":false,"given":"N\u00f3ra","family":"Bal\u00e1zs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1niel","family":"Bereczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7411","published-online":{"date-parts":[[2021]]},"container-title":["Ideggy\u00f3gy\u00e1szati szemle"],"original-title":[],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T06:12:45Z","timestamp":1638339165000},"score":1,"resource":{"primary":{"URL":"https:\/\/elitmed.hu\/en\/publications\/clinical-neuroscience\/cholinesterase-inhibitors-and-memantine-for-the-treatment-of-alzheimer-and-non-alzheimer-dementias"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":0,"journal-issue":{"issue":"11-12","published-online":{"date-parts":[[2021]]},"published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.18071\/isz.74.0379","relation":{},"ISSN":["0019-1442","2498-6208"],"issn-type":[{"value":"0019-1442","type":"print"},{"value":"2498-6208","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}